Psoriasis vs. Eczema: Understanding the Differences

Psoriasis and eczema both cause red, inflamed skin, but they are different conditions with distinct causes, symptoms, and treatments. Psoriasis is an [autoimmune disease](/what-is-psoriasis/) that produces thick, silvery scales on the elbows, knees, and scalp. Eczema (atopic dermatitis) is a barrier dysfunction condition that causes intensely itchy, dry patches, often in skin folds like the inner elbows and behind the knees.

When your skin is red, irritated, and won’t stop flaring, telling whether it’s psoriasis or eczema can be hard. Even doctors sometimes need a closer look. Getting the right diagnosis matters. These two conditions use different immune pathways, need different treatments, and carry different long-term health risks. This guide covers the key differences so you can talk with your dermatologist with more confidence.

What Does Psoriasis Look Like Compared to Eczema?

Psoriasis shows up as well-defined, raised patches covered with thick silvery-white scales. Eczema tends to look like dry, rough, red or dark patches with less clearly defined borders. On darker skin, psoriasis plaques may look violet or dark brown with gray scales. Eczema patches may look ashen gray or darker brown.

The visual differences can be subtle, but they follow patterns you can learn to spot.

Psoriasis plaques are usually sharply bordered. The skin is raised and covered with dead skin cells that form silvery or white scales. When you remove those scales, the skin underneath may bleed at tiny points. Doctors call this the Auspitz sign. Plaques feel thick and stiff. On lighter skin, they look pink to red. On darker skin, they can look purple, dark brown, or grayish.

Eczema patches tend to have less defined edges. The skin looks dry, rough, and swollen. During flares, the area may leak clear fluid or develop small blisters. Between flares, skin often feels leathery or thick from repeated scratching. This is called lichenification. Eczema rashes on darker skin may look brown, gray, or purple instead of red.

One practical clue: psoriasis scales feel dry and layered, almost like candle wax. Eczema skin feels rough and dry but rarely develops that thick, silvery scale.

Where Does Each Condition Appear on the Body?

Psoriasis tends to appear on the outer surfaces of the body: elbows, knees, lower back, and scalp. Eczema tends to appear where skin folds: the inner elbows, behind the knees, the neck, and the wrists. This location pattern is one of the best ways skin doctors tell them apart.

Location is one of the strongest clues for telling psoriasis and eczema apart.

Psoriasis commonly appears on:

• Outer elbows and knees
• Scalp (often extending past the hairline)
• Lower back and sacrum
• Hands and feet (palmoplantar psoriasis)
• Nails
• Skin folds (inverse psoriasis, which can mimic eczema)

Eczema commonly appears on:

• Inner elbows (antecubital fossa)
• Behind the knees (popliteal fossa)
• Neck and face
• Wrists and ankles
• Hands, especially the fingers
• Around the eyes

In babies and young children, eczema often starts on the cheeks and scalp before spreading. This can be confused with cradle cap or scalp psoriasis. Adults with eczema tend to flare in skin creases and folds where moisture and friction build up.

When Do Psoriasis and Eczema Typically Start?

Psoriasis has a bimodal age of onset, with the first peak between ages 15 and 25 and a second peak between 50 and 60. Eczema starts much earlier. About 60% of cases begin by age 1, and 90% show up before age 5. Many children with eczema get better by their teens. Psoriasis is usually lifelong.

Age of onset is a useful distinguishing factor.

Eczema is overwhelmingly a childhood condition. The National Eczema Association says 60% of people with atopic dermatitis get symptoms within their first year. Up to 90% are diagnosed before age 5. Many children outgrow eczema or improve a lot by their teens. About 20% to 30% still have symptoms as adults.

Psoriasis follows a different pattern. The condition has two distinct peaks. The first and most common peak is between ages 15 and 25, often set off by stress, infection, or hormonal changes. Knowing the different types of psoriasis helps your doctor pick the right treatment. A second, smaller peak appears between ages 50 and 60. The National Psoriasis Foundation says about 40% of people with psoriasis get symptoms before age 20.

If a rash starts in an infant, eczema is far more likely. If new scaly patches show up in a teen or young adult with no childhood skin issues, psoriasis becomes the top suspect.

How Does the Itch Differ Between Psoriasis and Eczema?

Eczema causes intense, lasting itching that is often the worst symptom of the disease. Psoriasis itch tends to feel like burning or stinging. It can be severe, but it isn’t always the main symptom. Eczema itch often worsens at night and can trigger a scratch-itch cycle that damages the skin further.

Both conditions itch, but the quality and intensity differ.

Eczema itch can be relentless. People with moderate to severe eczema call it the single worst part of the condition. It disrupts sleep, concentration, and daily functioning. The itch leads to scratching. Scratching damages the skin barrier, which causes more inflammation and more itch. Breaking this cycle is one of the main goals of eczema treatment.

Psoriasis itch has a different character. People often describe it as burning or stinging rather than the deep, crawling itch of eczema. Some people with psoriasis itch very little, while others find it severe. A 2019 study found about 70% of people with psoriasis called itching bothersome. Over 85% of people with eczema rated itch as their top concern.

Scratching psoriasis plaques can trigger what doctors call the Koebner effect. This is when new plaques form where the skin was injured. This is one more reason dermatologists tell patients not to scratch psoriasis, even when it itches.

What Causes Psoriasis vs. Eczema?

In psoriasis, an overactive immune system speeds up skin cell production. The Th17 pathway and proteins called IL-17 and IL-23 drive this process. Eczema results from a weak skin barrier and an overactive Th2 immune response. Proteins called IL-4 and IL-13 are involved. These different immune pathways are why the two conditions need different targeted treatments.

Psoriasis and eczema have very different biology, even though both involve inflammation.

Psoriasis: Autoimmune and Th17-Driven

In psoriasis, the immune system wrongly attacks healthy skin cells. White blood cells called T cells become active and trigger inflammation through the Th17 pathway. IL-17 and IL-23 are the key proteins that drive rapid skin cell growth. A healthy skin cell takes about 28 to 30 days to grow and shed. In psoriasis, that cycle speeds up to 3 to 4 days. Cells pile up on the surface faster than they can shed. This forms the thick plaques.

Eczema: Barrier Dysfunction and Th2-Driven

Eczema starts with a defective skin barrier. The outer skin layer (the stratum corneum) doesn’t hold moisture or block irritants as it should. This breakdown triggers the Th2 part of the immune system. It releases proteins like IL-4 and IL-13 that cause inflammation. Allergens, bacteria, and irritants get through the weak barrier more easily. This keeps the cycle of inflammation going.

Genetic Differences

The genetic underpinnings are also distinct. Psoriasis is strongly linked to changes in the HLA-Cw6 gene. This gene is part of how the immune system recognizes threats. About 60% to 65% of people with early-onset psoriasis have this gene change, per Nature Reviews Immunology.

Eczema is closely linked to changes in the filaggrin gene (FLG). This gene makes a protein needed to build and maintain the skin barrier. About 20% to 30% of people with eczema carry at least one filaggrin gene change. In the general population, only 8% to 10% do. Filaggrin gene changes that stop the protein from working are the strongest known genetic risk factor for eczema.

What Triggers Flares for Each Condition?

Psoriasis flares are commonly triggered by stress, skin injuries (Koebner phenomenon), infections like strep throat, certain medications, and cold weather. Eczema flares are more closely tied to allergens (dust mites, pet dander), harsh soaps and detergents, sweating, and bacterial skin infections. Stress triggers both conditions.

Psoriasis and eczema share some triggers but differ in key ways.

Common psoriasis triggers:

• Stress (emotional or physical)
• Skin injuries, cuts, or sunburns (Koebner phenomenon)
• Infections, particularly strep throat
• Certain medications (lithium, beta-blockers, antimalarials, rapid steroid withdrawal)
• Smoking and heavy alcohol use
• Cold, dry weather

Common eczema triggers:

• Contact with allergens (dust mites, pet dander, pollen, certain foods)
• Harsh soaps, detergents, and fragrances
• Temperature changes and sweating
• Dry air and low humidity
• Stress
• Rough fabrics like wool
• Bacterial skin infections, particularly Staphylococcus aureus

One key difference: infections trigger psoriasis from inside the body (strep throat starts an immune reaction). They affect eczema from the outside (bacteria grow on the damaged skin). Eczema is also much more closely tied to allergic conditions. About 50% to 70% of children with moderate to severe eczema later develop asthma or hay fever. Doctors call this the atopic march.

How Do Treatments Overlap and Differ?

Psoriasis and eczema share some basic treatments: moisturizers, topical steroids, and light therapy. But their biologic drugs are very different because they block different immune pathways. Psoriasis biologics target IL-17 or IL-23, while eczema biologics target IL-4 and IL-13. Using the wrong biologic can make the other condition worse.

Treatments That Work for Both

• Moisturizers and emollients help both conditions by supporting skin barrier function
• Topical corticosteroids reduce inflammation in both diseases, though psoriasis often needs stronger potencies
• Phototherapy (narrowband UVB light therapy) can improve both conditions, though the treatment protocols differ
• Topical calcineurin inhibitors (tacrolimus, pimecrolimus) are FDA-approved for eczema and sometimes used off-label for facial or genital psoriasis

Psoriasis-Specific Treatments

The biologic revolution has transformed psoriasis treatment. These medications target specific parts of the immune pathway:

• IL-17 inhibitors: secukinumab (Cosentyx), ixekizumab (Taltz), brodalumab (Siliq), bimekizumab (Bimzelx, approved October 2023). Bimekizumab blocks both IL-17A and IL-17F and achieved 90% skin clearance (PASI 90) in about 85% of people in Phase 3 trials.
• IL-23 inhibitors: guselkumab (Tremfya), risankizumab (Skyrizi), tildrakizumab (Ilumya). These need fewer doses (often every 8 to 12 weeks after a loading phase) and show lasting results.
• TNF inhibitors: adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade). These were the first biologics for psoriasis and are still used. Newer options often clear skin better.
• Oral options: apremilast (Otezla, a PDE4 inhibitor) and deucravacitinib (Sotyktu, a TYK2 inhibitor approved in 2022).

Eczema-Specific Treatments

• Dupilumab (Dupixent): An IL-4/IL-13 blocker that was the first biologic approved for moderate to severe atopic dermatitis. Studies show about 40% of people treated achieve clear or almost clear skin at 16 weeks.
• Tralokinumab (Adbry): Targets IL-13 specifically.
• JAK inhibitors: abrocitinib (Cibinqo) and upadacitinib (Rinvoq) are oral pills that block Janus kinase signaling. They can work faster than biologics but need more safety monitoring. Risks include blood clots and infections.
• Topical JAK inhibitor: ruxolitinib cream (Opzelura) for mild to moderate eczema.

Using a psoriasis biologic for eczema, or vice versa, won’t help and may cause harm. A 2020 report in the British Journal of Dermatology found eczema flares in people getting IL-17 drugs for psoriasis.

How Do Comorbidities Compare?

Psoriasis comorbidities tend toward cardiovascular disease, metabolic syndrome, and psoriatic arthritis. Eczema comorbidities cluster around allergic conditions like asthma and food allergies, a progression called the atopic march. Both conditions carry elevated rates of depression and anxiety.

Psoriasis and eczema come with different related health problems.

Psoriasis comorbidities tend to involve cardiovascular and metabolic risk. People with moderate to severe psoriasis have higher rates of heart disease, metabolic syndrome, type 2 diabetes, and fatty liver disease. A 2019 study in JAMA Dermatology found severe psoriasis raised heart risk by about 53%. Psoriatic arthritis causes joint pain, swelling, and stiffness. It affects about 30% of people with psoriasis.

Eczema comorbidities cluster around allergic and mental health conditions. The atopic march links eczema to asthma, allergic rhinitis, and food allergies. People with eczema also have much higher rates of anxiety and depression, partly from chronic itch and poor sleep. A 2023 study found adults with eczema were 44% more likely to report anxiety symptoms.

How Do Psoriasis and Eczema Affect the Nails?

Both conditions can affect fingernails and toenails, but the patterns are different. Psoriasis nails often show pitting (small dents), yellow-brown spots, thickening, and lifting from the nail bed (onycholysis). Eczema nail changes tend to include ridges, rough texture, and swollen cuticles, not the pitting seen in psoriasis.

Nail involvement can help a dermatologist lean toward one diagnosis. Nail psoriasis is common. Up to 50% of people with skin psoriasis and 80% of those with psoriatic arthritis have it, per the National Psoriasis Foundation. The pitting pattern, tiny ice-pick-like dents on the nail surface, is a hallmark sign.

Eczema-related nail changes are less specific. You may see uneven ridges, a rough texture, or inflamed skin around the cuticle and nail fold (periungual dermatitis). These changes come from skin inflammation near the nail affecting how it grows.

Can You Have Both Psoriasis and Eczema?

Having both psoriasis and eczema at the same time is uncommon but possible. The two conditions involve different and somewhat opposing immune pathways (Th17 vs. Th2), which limits how often they coexist. Diagnostic overlap is more common than truly having both. A skin biopsy can help sort out unclear cases.

Having both conditions at the same time is uncommon but possible. The two diseases use different and somewhat opposing immune pathways (Th17 vs. Th2). So they don’t coexist as often as other skin conditions. Some dermatologists question whether both truly exist at once, or whether some people just have features that look like both.

What does happen more commonly is diagnostic uncertainty. Some types of psoriasis, especially inverse psoriasis in skin folds, can look a lot like eczema. Chronic hand eczema can also look a lot like palmoplantar psoriasis. In these ambiguous cases, a dermatologist may need a skin biopsy to settle the question.

Children present another challenge. A child with severe eczema who later gets scaly plaques on the elbows and knees as a teen may be developing psoriasis, not having both at once.

Getting the Right Diagnosis

Dermatologists diagnose psoriasis and eczema based on clinical appearance, location, patient history, and family history. When the diagnosis is unclear, a skin biopsy can show distinct microscopic patterns. Psoriasis biopsies reveal thickened epidermis with elongated rete ridges and neutrophil collections, while eczema biopsies show spongiosis (fluid between skin cells) and a different inflammatory pattern.

If you have a red, itchy skin condition and aren’t sure what it is, or if your treatment isn’t working, try these steps.

See a dermatologist, not just a primary care doctor. Dermatologists diagnose skin conditions all day. A 2018 study found primary care doctors misdiagnosed psoriasis about 26% of the time. They often called it eczema or a fungal infection.

Bring your history. Tell your doctor when symptoms started, where they show up, what helps or worsens them, and any family history of skin conditions or allergies.

Ask about biopsy if there’s uncertainty. A skin sample viewed under a microscope can usually confirm whether it is psoriasis or eczema. Psoriasis shows longer rete ridges (finger-like skin growths), thinner skin over the papillae, and clusters of white blood cells. Eczema shows spongiosis, where fluid collects between skin cells and creates a sponge-like look.

Get tested for psoriatic arthritis. If you have psoriasis and get joint pain, stiffness, or swelling, tell your dermatologist. Treating psoriatic arthritis early can prevent lasting joint damage.

Frequently Asked Questions

Can psoriasis turn into eczema or vice versa?

No. Psoriasis and eczema are separate diseases with different genetic and immunologic causes. One doesn’t become the other. If your skin condition appears to change character, you may have been initially misdiagnosed or you could be developing a second condition.

Is psoriasis contagious?

No. Psoriasis is an autoimmune condition and cannot spread to other people through touch, shared clothing, or any other form of contact. The same is true for eczema.

Which is more common, psoriasis or eczema?

Eczema is more common overall, affecting an estimated 31.6 million Americans (about 10% of the population). Psoriasis affects about 7.5 million Americans (roughly 2% to 3% of the population), according to the National Psoriasis Foundation.

Can diet affect psoriasis or eczema?

Some evidence suggests anti-inflammatory diets (Mediterranean-style eating patterns) may help reduce psoriasis flares. For eczema, food allergies can trigger flares in some people, particularly children, but blanket elimination diets aren’t recommended without allergy testing. Talk to your doctor before making major dietary changes.

Do psoriasis and eczema have the same treatments?

There’s some overlap in basic treatments like moisturizers, topical steroids, and phototherapy. But the targeted biologic therapies are completely different because they address different immune pathways. Psoriasis biologics target IL-17 or IL-23, while eczema biologics target IL-4 and IL-13.

Are people with eczema more likely to develop psoriasis?

Having eczema doesn’t significantly increase your risk of developing psoriasis. The two conditions involve different immune pathways and genetic risk factors. A family history of psoriasis is a much stronger predictor than personal eczema history.

When should I see a dermatologist about my skin condition?

See a dermatologist if your skin symptoms haven’t responded to over-the-counter moisturizers and hydrocortisone cream after two to four weeks, if your symptoms are spreading or worsening, if you’re losing sleep due to itch, or if you’re unsure whether you have psoriasis or eczema. An accurate diagnosis is the first step toward effective treatment.

Can children have psoriasis?

Yes. While psoriasis is less common in young children than eczema, about 40% of people with psoriasis develop their first symptoms before age 20. In children, psoriasis often starts on the scalp and can be mistaken for cradle cap or eczema. Guttate psoriasis, which causes small teardrop-shaped spots, is particularly common in children and teenagers, often appearing after a strep throat infection.

Sources and References

1. National Psoriasis Foundation. “About Psoriasis.” psoriasis.org/about-psoriasis
2. National Eczema Association. “Atopic Dermatitis.” nationaleczema.org/eczema/types-of-eczema/atopic-dermatitis
3. Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. “Psoriasis.” The Lancet. 2021;397(10281):1301-1315.
4. Langan SM, Irvine AD, Weidinger S. “Atopic dermatitis.” The Lancet. 2020;396(10247):345-360.
5. Nestle FO, Kaplan DH, Barker J. “Psoriasis.” New England Journal of Medicine. 2009;361(5):496-509.
6. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. “Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.” Nature Genetics. 2006;38(4):441-446.
7. Takeshita J, Grewal S, Langan SM, et al. “Psoriasis and comorbid diseases: Epidemiology.” Journal of the American Academy of Dermatology. 2017;76(3):377-390.
8. Silverberg JI, Gelfand JM, Margolis DJ, et al. “Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults.” Annals of Allergy, Asthma & Immunology. 2018;121(5):604-612.
9. Gordon KB, Foley P, Krueger JG, et al. “Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial.” The Lancet. 2021;397(10273):475-486.
10. Simpson EL, Bieber T, Guttman-Yassky E, et al. “Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.” New England Journal of Medicine. 2016;375(24):2335-2348.
11. Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM. “The prevalence of atopic dermatitis beyond childhood: A systematic review and meta-analysis of longitudinal studies.” Allergy. 2018;73(3):696-704.
12. Naldi L. “Epidemiology of psoriasis.” Current Drug Targets. 2004;5(1):53-57.
13. Egeberg A, Skov L, Gislason GH, et al. “Cardiovascular risk and psoriasis.” JAMA Dermatology. 2019;155(10):1145-1152.

Psoriasis Daily is strictly a news and information website about psoriasis. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.